Emergent BioSolutions’ plant behind the lost J&J vaccine batch hit with several FDA red flags last year: report
With Johnson & Johnson’s COVID-19 vaccine rollout off to a slower than expected start, the recent news that millions of doses were ruined in a production error came as a rude awakening. But the Emergent BioSolutions plant at the heart of the issue has faced scrutiny for its shortcomings from federal regulators before. An FDA investigator last… Read More »
